The Devyser blog

Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...

As a lab manager, you know the importance of streamlining workflows to maximize productivity and...

Devyser´s annual report 2022 has today been published on the company´s website. The report is...

Devyser announced in Aug 2022 that we received our first IVDR certificate from the notified body...

With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...

Devyser, the pioneering leader in diagnostic solutions, launches today its first IVDR-certified...

Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with...

“Further strong organic growth was reported for the year and quarter. Efforts to build an...

We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for...

Relapse of the underlying malignant disease is a major complication after hematopoietic stem cell...

This episode is dedicated to the 10-year anniversary of Genomics England's 100,000 Genomes Project...